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Abstract: 
Introduction: Obesity is an independent risk factor for erectile dysfunction (ED) and lower 
urinary tract symptoms (LUTS). Bariatric surgery has been shown to improve erectile function 
and urinary symptoms in previous medium to long term studies (3-12 months post-operative 
follow up).  
The aim: is to investigate the early effect (1 month post-op) of bariatric surgery on ED and 
LUTS which has not previously been investigated.  
Methods: Morbidly obese men (BMI >35 kg/m2) undergoing bariatric surgery were asked to 
complete International Index of Erectile Function (IIEF) and International Prostate Symptom 
Score (IPSS) questionnaires before the surgery and 1, 3 and 6 months after the surgery.  
Main outcome measure: The influence of bariatric surgery on urogenital function, BMI, 
fasting blood glucose (FBG) and HbA1C were analysed using parametric and non-parametric 
tests for paired samples. 
Results: Out of 30 patients who have completed the study, 18 reported erectile dysfunction 
(ED; IIEF<25) and 14 reported moderate-severe LUTS (IPSS ≥8) before the operation. 12 
patients had both ED and moderate-severe LUTS. IIEF, IPSS, BMI, percentage weight loss, FBG 
and HbA1c all improved significantly and rapidly after the bariatric surgery starting at the 1 
month post-operative time point and continued to improve throughout the study in all 
patients with ED or moderate to severe LUTS.  
Conclusions: This is the first study showing improvement in erectile and urinary function 
within 1 month after the bariatric surgery; an effect that was in parallel with glycaemic 
improvement and weight loss.  
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Introduction: 
According to the World Health Organisation definition, overweight (BMI≥25 kg/m2) and 
obesity (BMI≥30 kg/m2) is an abnormal or excessive fat accumulation that may impair overall 
health 1,2 . With an increasing number of overweight or obese people globally, obesity has 
now been recognised as an epidemic affecting the health of populations mainly through 
obesity-related diseases such as Type 2 diabetes, cardiovascular diseases and stroke 1,3. It is 
therefore not surprising that obesity has been identified as an independent risk factor for 
erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) 4-8.  
Corona et al. (2009) suggested that obesity is directly related to lower androgen levels in men 
who suffer from ED, and that obesity related comorbidities, particularly hypertension, are 
considered significant causes of arteriogenic obesity-related ED 9. The association between 
obesity and ED can be partly explained through increased levels of various pro-inflammatory 
cytokines in obese people 10. These signs of inflammation have a strong connection with 
endothelial dysfunction, which is directly related to ED through the nitric oxide pathway 11. 
Similarly LUTS has been suggested to be caused by microvascular dysfunction 12 which can be 
observed in obese men 13. Other hypotheses for LUTS in obesity are increased oestrogen to 
testosterone ratio 4, which may play a role in prostate tissue hyperplasia, increased prostate 
volumes 14 and increased sympathetic nervous system activity 15. 
 
Weight loss either through non-surgical methods (i.e. diet, medication, exercise) or surgical 
methods (i.e. bariatric surgery) has been shown to improve both erectile 16,17  and urinary 
function 1618. The improvement following bariatric surgery has been more effective and 
longer-lasting than the non-surgical approaches 17. Previous studies on the effect of bariatric 
surgery on ED and LUTS have investigated time points 3-12 months and over after the surgery. 
Although all of these studies have shown a significant improvement in erectile 16,19,20,21,22 and 
urinary function 19,22 , the improvement was parallel to the weight loss. The patients had 
achieved significant weight loss while their urogenital function improved.  
It is known that bariatric surgery can have an acute glycaemic effect: as short as 48 hours after 
the operation, the patients are known to have improved blood glucose levels 3,23,24,25. Hence 
bariatric surgery has been coined as a “surgical treatment for diabetes” 26. Although the exact 
mechanism of this phenomenon is currently unknown, this suggests that glycaemic 
improvement may potentially precede weight loss after the bariatric surgery in the early post-
operative phase. We therefore assessed the urogenital function of morbidly obese men 
(BMI>35 kg/m2 with obesity-related comorbidity) pre-operatively and at 1, 3 and 6 months 
after bariatric surgery.  
 
 
 
Materials and Methods: 
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Patient selection: Male patients listed for bariatric surgery who had BMI >35 kg/m2 with 
obesity-related comorbidity or BMI >40 kg/m2 2, age over 30 years (47.2 ±8.1) and were able 
to read and understand the questionnaires were included in the study from February 2013 to 
July 2015. Patients were excluded if they were not sexually active or were younger than 30 or 
older than 75. None of the patients were treated or had received prior treatment for ED or 
LUTS. 
Data collection: The patients were given International Index of Erectile Function (IIEF) 27 and 
International Prostate Symptom Score (IPSS) 28 questionnaires to complete, their weight and 
height were measured and venous blood was drawn from the study participants  following 
UCLH guidelines to measure fasting blood glucose (FBG) and glycated haemoglobin (HbA1c) 
concentrations were measured using hexokinase method and cation exchange 
chromatography respectively 1 month before the surgery and 1, 3 and 6 months after the 
surgery. 
Data analysis: Statistical analysis was performed using the statistical software SPSS version 
22 (SPSS Inc., Chicago, IL, USA) for Windows, to perform exploratory data analysis and 
produce descriptive statistics. Normal distribution was assessed using skewness test 29. Non-
normally distributed data are presented as median and interquartile range (IQR) while 
normally distributed data are presented as mean ± standard deviation.  Non-parametric 
Wilcoxon signed rank test was used to compare repeated measurements between two time 
points for non-normally distributed data. Paired t-test was used to compare repeated 
measurements between two time points for normally distributed data. Mann Whitney U test 
was performed to compare the differences between the two groups for non-normally 
distributed data 29. Percentage of total weight loss (%TWL) was used in order to describe the 
weight loss after bariatric surgery 30.  
Ethical considerations: The data was collected from a planned clinical audit at XXXXXXX. The 
project was approved by Ethics Committee of XXXXX University XXXXXX (XXXXXX 03.13 on 
13th February 2013). Informed written consent was obtained from all patients.  
 
 
 
 
 
 
 
 
Results: 
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Baseline characteristics: ED vs NO-ED  
49 patients were initially assessed for the study, 14 of them withdrew from the study and 5 
were found to be not sexually active. The remaining 30 patients that were included in the 
study were arbitrarily divided into NO-ED (IIEF erectile function domain score >25; n=12) and 
ED (IIEF erectile function domain score <25; n=18) groups. The baseline characteristics of the 
two groups are shown in Table 1. The IIEF scores in all domains were lower in ED group than 
NO-ED group. IPSS scores were higher in ED group than NO-ED group except in frequency, 
intermittency, strain and nocturia. There was no significant difference between the two 
groups in age, BMI, FBG and HbA1c (Table 1).  
Baseline characteristics: No-Mild LUTS vs Moderate-Severe LUTS 
When a similar analysis was performed based on their IPSS scores, the patients were 
arbitrarily divided into two groups: No LUTS or mild LUTS (NO-MILD LUTS group; total IPSS 
score < 8; n=16) and moderate or severe LUTS (MODERATE-SEVERE LUTS group; total IPSS 
score > 8; n=14). The baseline characteristics of the two groups are shown in Table 2. The 
patients in MODERATE-SEVERE LUTS group were older and had lower scores in total IIEF, 
erectile function, intercourse satisfaction and overall satisfaction domains than NO-MILD 
LUTS group. In all IPSS domains MODERATE-SEVERE LUTS group had higher scores than NO-
MILD LUTS groups. There was no significant difference between the two groups in BMI, FBG 
and HbA1c (Table 2). 
Surgery types: 
All patients underwent laparoscopic sleeve gastrectomy, laparoscopic gastric bypass or 
laparoscopic gastric band operations. There was no statistical difference between the ED or 
NO-ED groups with respect to the type of operation they received. Within the ED group 44.4%, 
33.3% and 22.3% of patients received sleeve, bypass and band respectively. The percentages 
were 41.6%, 25.1% and 33.3% for sleeve, bypass and band respectively for the patients in NO-
ED group (P=0.421). Similarly there was no difference between NO-MILD LUTS and 
MODERATE-SEVERE LUTS groups with respect to the type of operation they received (P=0.89). 
Within the NO-MILD LUTS group 43.8%, 31.3% and 25.0% of patients received sleeve, bypass 
and band respectively. The percentages were 42.9%, 28.6% and 28.6% for sleeve, bypass and 
band respectively for the patients in MODERATE-SEVERE LUTS group. 
Effect of bariatric surgery on BMI and %TWL: 
In both ED and NO-ED groups, a significant decrease in BMI (Figure 1A) and increase in %TWL 
(Figure 1B) was observed after the surgery. The weight loss reached statistical significance at 
1 month and continued throughout to 6 months (Figure 1). There was no statistically 
significant difference between ED and NO-ED groups at any time points.  
Similarly when the patients were divided into NO-MILD LUTS and MODERATE-SEVERE LUTS 
groups, a significant decrease in BMI (Figure 2A) and a significant increase in %TWL (Figure 
2B) were observed after the surgery (P<0.01).  The weight loss reached statistical significance 
at 1 month and continued throughout to 6 months (Figure 2). There was no statistically 
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significant difference between NO-MILD LUTS and MODERATE-SEVERE LUTS groups at any 
time points.  
Effect of bariatric surgery on erectile function: 
In the ED group, the surgery caused a significant increase in the total IIEF score at 3 months; 
the median of the baseline, 1, 3 and 6 months post-operation total IIEF scores were 35.0 , 
39.0 , 60.0  and 66.5 respectively (1, 3 and 6 months significantly different from baseline, 
(P=0.02, P=0.001 and P<0.001 respectively; Figure 3A). The earliest increase within the 
domains was observed in erectile function and intercourse satisfaction domains starting at 1 
month (Figure 3B and 3C). The increase in the other domains (orgasmic function, sexual desire 
and overall satisfaction) reached significance at 3 months and further increased at 6 months 
(Figure 3C).  
In the NO-ED group, while patients started with high scores pre-operatively, the median of 
the total IIEF scores were 68.5 , 68.5 , 72.0  and 72.0 pre-operatively, 1, 3, and 6 month post-
operatively respectively with no significant changes (Figure 3A). Although a decrease in 
erectile function domain score was observed at 1 month post-operatively (Supplementary 
Figure 1A), the change was not statistically significant. The only significant increase was 
observed in sexual desire and intercourse satisfaction domains at 6 months (Supplementary 
Figure 1B).  
In the MODERATE-SEVERE LUTS group, the median of total IIEF scores were 32.5 , 32.0 , 59.0  
and 66.0 at the baseline and 1, 3 and 6 months post-operatively respectively showing a 
significant increase at 3 and 6 months from baseline (P=0.003 and P=0.002 respectively; 
Supplementary Figure 2A). All domains showed a significant improvement after the surgery; 
erectile function, intercourse satisfaction and overall satisfaction improved at 1 month while 
the other domains reached significance at 3 months (Supplementary Figure 2B and 2C).   
In the NO-MILD LUTS group, although total IIEF scores were high pre-operatively, a significant 
increase was still observed at 3 and 6 months post-operatively (the median of the total IIEF 
scores were 64.5 , 57.0 , 72.0  and 71.5 pre-operatively, 1, 3, and 6 month post-operatively 
respectively with significant changes at 3 and 6 months (P=0.02, P=0.015; Supplementary 
Figure 2A).  The significant changes were observed in desire, intercourse satisfaction, 
orgasmic function and overall satisfaction domains at 6 months post-operative time points 
(Supplementary Figure 2B and 2C).  
In overall, out of 18 patients with ED (total IIEF score <25) before the surgery, 4, 8 and 12 of 
them were re-classified as NO-ED at 1, 3 and 6 months post-operatively respectively.   
Effect of bariatric surgery on urinary function: 
In the ED group, a significant improvement in total IPSS score was observed: the median total 
IPSS scores were 12.5, 8.5, 4.0 and 2.0 for pre-operative and 1, 3 and 6 months post-operative 
time points (P=0.002, P=0.001 and P=0.001) respectively (Figure 4A).  The improvements in 
frequency, intermittency, weak stream, nocturia and quality of life domain scores were 
observed at 1 month which further improved throughout the study. The decrease in urgency 
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and incomplete emptying domain scores reached significance at 3 months. There was no 
significant change in straining domain score throughout the study (Figure 4B).   
In the NO-ED group, with most of the patients starting with near normal low scores, the only 
effects of surgery observed were a significant increase in quality of life domain score at 1 
month which decreased back to normal at 3 months and a significant decrease in nocturia 
domain score at 6 months (Supplementary Figure 3).  
In MODERATE-SEVERE LUTS group, a significant decrease in total IPSS score was observed: 
the total median scores were 14.5, 11.0, 7.0 and 2.5 for pre-operative and 1, 3 and 6 months 
post-operative time points respectively (P=0.001, P<0.001 and P<0.001; Figure 5A). Significant 
improvements in frequency, intermittency, weak stream and nocturia domains were 
observed at 1 month post-operatively while the other domains (incomplete emptying, 
urgency and quality of life) reached significance at 3 months (Figure 5B). In straining domain, 
a significant improvement was observed at 3 months which did not continue at 6 months 
(Figure 5B).  
In NO-MILD LUTS group, the IPSS scores were low pre-operatively. A further decrease in total 
IPSS score was observed but this was not significant. Significant improvements in nocturia and 
urgency domains were observed at 3 and 6 months post-operative time points. There were 
no significant changes in any of the other domains at any time points (Supplementary Figure 
4).  
In overall, out of 14 patients with MODERATE-SEVERE LUTS (total IPSS score >8) before the 
surgery, 1, 7 and 9 of them were re-classified as NO-MILD LUTS at 1, 3 and 6 months post-
operatively. 
Effect of bariatric surgery on glycaemic indices: 
At baseline, 7 (39%) and 11 (61%) patients with ED (n=18) had FBG and HbA1c levels above 
the normal range respectively (5.8 mmol/l and 42 mmol/mmol respectively). In NO-ED group 
(n=12) the number of patients above the normal range were 5 (42%) and 6 (50%) respectively; 
there was no statistical difference between the two groups (P>0.05). In both ED and NO-ED 
groups, a decrease in FBG and HbA1c concentrations was observed after the surgery starting 
at 1 month and with a further decrease throughout the study. The decrease in FBG reached 
significance at 1 month in ED group while at 6 months in NO-ED group. The decrease in HbA1c 
reached significance at 1 month in both ED and NO-ED groups (Figure 6A and 6B).  
In both NO-MILD LUTS and MODERATE-SEVERE LUTS groups, a decrease in FBG and HbA1c 
concentrations was observed after the surgery starting at 1 month and with a further 
decrease throughout the study (Figure 7A and B).  
Interestingly, although the decrease in HbA1c in ED or MODERATE-SEVERE LUTS groups was 
significant, it was not sufficient to bring the HbA1c levels below the recommended threshold 
(42 mmol/mmol). This was achieved in NO ED or NO-MILD LUTS groups (Figure 6B and 7B). 
Discussion: 
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Bariatric surgery, whether gastric bypass or sleeve banding, resulted insignificant weight loss 
as early as 1 month in our study. By 6 months, all of the patients have almost reached 20-25% 
weight loss which is comparable to other studies with similar post-operative follow up 
duration 16,22,31,32,33.    
Previous studies investigating the effect of bariatric surgery on erectile function have shown 
a significant improvement at the earliest time point of 12 months 16202122. A longer study of 
10 years has shown a decline in erectile function most probably due to ageing 34. A recent 
study has shown a significant effect at 3 months 22. The authors have demonstrated a 
significant improvement in all domains of IIEF questionnaire at 3 months post-operatively. 
This is in accordance with our findings where all of the domains reached significant 
improvement at 3 months. Interestingly at 1 month, only erectile function and intercourse 
satisfaction were significantly improved in our study.  
Several studies suggested the reasons behind the improvement in sexual function after 
bariatric surgery; Mora and colleagues (2013) suggested that this was, due to the weight 
reduction occurring after bariatric surgery further than the parallel improvement in 
testosterone level and metabolic profiles such as insulin sensitivity, C-reactive protein and 
lipid profile 21. Reis et al suggested the role that oestrogens may play in erectile function 
since they show a significant increase in the hormone levels with BMI reduction following 
bariatric surgery 16. Another factor suggested for this improvement is the acute reduction of 
FBG 22.  
A correlation of testosterone and other hormone levels to erectile function has been 
suggested by previous studies 3237. According to Corona et al. (2016) meta-analysis shows that 
testosterone has a principal role in controlling male sexual desire and hormone replacement 
therapy can improve low desire and erectile dysfunction in hypogonadal individuals 38. 
Hormone levels were not measured in our study which should be highlighted as a limitation. 
Likely, the acute improvement in intercourse satisfaction after one month post-operative in 
our study might be due to psychosocial reasons, which may have improved after the weight 
loss 39,40. Sexual desire was the least improved domain in our study. This can be explained by 
the effect of major surgery on the patient’s overall wellbeing (i.e. patients may be feeling tired 
after the surgery hence not interested in sex).  
Most of the previous studies investigating the effect of bariatric surgery on urinary function 
have focused on urinary incontinence and overactive bladder symptoms in women 4142. The 
studies on bariatric surgery and LUTS in men are limited.  A recent study looked into the IPSS 
scores of men at 6 weeks and 1 year following bariatric surgery. They found significant weight 
loss and improvement in urgency and frequency at 6 weeks 43. Although we have observed 
significant improvement in frequency, intermittency, weak stream, nocturia and quality of life 
in 1 month after the surgery in ED group, the improvement in urgency did not reach 
significance until 3 months. This may be due to the difference in statistical methods employed 
in the two studies; furthermore Luke et al did not stratify their patients according to their IIEF 
scores. Nevertheless, the significant improvement in IPSS scores in ED group but not in NO-
ED group which had near normal scores before the operation further highlights the 
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importance of the link between ED and LUTS and the necessity of investigating both erectile 
and urinary function together in men with obesity.  
It was interesting to observe that fasting blood glucose and HbA1c levels were reduced 
significantly and rapidly after the bariatric surgery in all patients. Such an acute glycaemic 
improvement following bariatric surgery has been reported previously 2326. We have observed 
in our study that the decrease in HbA1c levels in the patients with ED or MODERATE-SEVERE 
LUTS was not as dramatic as other patients. Although it is very difficult to draw any 
conclusions from such a small group of patients, this may be due the fact that these patients 
may have had high HbA1c levels longer than the others which may be one of the underlying 
causes of their urogenital dysfunction. 
 Several limitations to our study merit further discussion. The small sample size of the study 
groups might have overestimated the correlations between variables. Another important 
consideration is that the study patients may not be a random sample of the male morbidly 
obese population due to the lack of randomisation. However, the groups (ED vs NO-ED and 
NO-MILD LUTS vs MODERATE-SEVERE LUTS) were well matched for pre-operative patient 
characteristics. The lack of a control group in the study prevents the assessment of the 
prevalence of impaired sexual function in patients who did not undergo bariatric surgery over 
time. Moreover, it is known that serum testosterone and aromatase enzyme levels are crucial 
in determining erectile and urological function and that obesity can influence such levels 44. 
Measurement of serum testosterone and aromatase levels at the same time points would 
add further to our understanding of the mechanism underlying the observed improvements 
in function. 
 
 
 
 
 
 
 
 
 
 
Conclusions: 
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ED and LUTS are commonly observed in obese men. Bariatric surgery may possibly improve 
erectile and urinary function as well as glycaemic indices. Our study is the first study showing 
such improvement in both functions as early as 1 month following bariatric surgery. 
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Table 1: Baseline characteristics of the patients before the bariatric surgery 
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ED Group 
(n=18) 
NO-ED Group 
(n=12) 
Statistical 
difference 
Age (years)  48.9 ± 7.0 44.1 ± 6.9 P=0.12 
Height (m)  1.8 (1.7, 2.0) 1.8 (1.6, 1.9) P=0.94 
Weight (kg)  147.1 (94.8, 232.5)  143.9 (107.9, 230.1) P=0.71 
BMI (kg/m2)   46.8  (37.9, 61.9)  47.8 (37.1, 69.5)  P=0.09 
FBG (mmol/l)  5.3 (4.6, 8.3) 5.4 (4.4, 14.9) P=0.07 
HbA1c (mmol/mol) 43.5 (37.0, 58.0) 44.0 (32.0, 95.0) P=0.09 
IIEF total score 35.0  (13.0, 64.0 ) 68.5 (51.0, 74.0) P=0.03 
IIEF EF domain 13.0 (2.0, 25.0) 29.0 (27.0, 30.0) P=0.02 
IIEF OF domain 8.0 (1.0, 10.0) 10.0 (6.0, 10.0) P=0.02 
IIEF SD domain 6.0 (2.0, 8.0) 8.5 (4.0, 10.0) P=0.004 
IIEF IS domain 6.0 (0.0, 13.0) 12.5 (6.0, 15.0) P=0.002 
IIEF OS domain 5.5 (2.0, 10.0) 9.0 (4.0, 10.0) P=0.001 
IPSS total score 12.5 (0.0, 28.0) 4.5 (1.0, 14.0) P=0.01 
IPSS IE  1.5 (0.0, 5.0) 0.0 (0.0, 2.0) P=0.02 
IPSS Freq  2.0 (0.0, 5.0) 0.5 (0.0, 5.0) P=0.08 
IPSS Intermit  1.5 (0.0, 5.0) 0.0 (0.0, 4.0) P=0.09 
IPSS Urgency  2.0 (0.0, 5.0) 0.0 (0.0, 3.0) P=0.01 
IPSS Weak stream  1.0 (0.0, 2.0) 0.0 (0.0, 2.0) P=0.01 
IPSS Strain  0.0 (0.0, 2.0) 0.0 (0.0, 1.0) P=0.98 
IPSS Nocturia  1.0 (0.0, 5.0) 1.0 (0.0, 3.0) P=0.92 
IPSS QoL  12.5 (0.0, 28.0) 4.5 (1.0, 14.0) P=0.002 
(EF: erectile function; OF: orgasmic function; SD: sexual desire; IS: intercourse satisfaction; OS: overall 
satisfaction; IE: incomplete emptying; Freq: frequency; Intermit: intermittency; Strain: straining; QoL: quality of 
life). 
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Table 2: Baseline characteristics of NO-MILD LUTS vs MODERATE-SEVERE 
LUTS 
 
 
NO-MILD LUTS 
Group 
(n=16) 
MODERATE-SEVERE 
LUTS Group 
(n=14) 
Statistical 
difference 
Age (years)  46.1 ± 7.0 49.1 ± 9.8 P=0.03 
Height (m)  1.8 (1.64, 2.01) 1.8 (1.7, 1.94) P=0.35 
Weight (kg)  147.5 (94.8, 230.1)  149.3 (112.1, 232.5) P=0.73 
BMI (kg/m2)   47.5  (37.9, 69.5)  45.0 (37.9, 69.5)  P=1.0 
FBG (mmol/l)  5.3 (4.5, 14.9) 5.4 (4.7, 8.3) P=0.73 
HbA1c (mmol/mol) 44.5 (39.0, 56.0) 43.5 (37.0, 58.0) P=0.94 
IIEF total score 64.0  (13.0, 74.0 ) 32.5 (23.0, 62.0)  p<0.01 
IIEF EF domain 28.0 (2.0, 30.0) 17.7 (14.6, 20.2)  p=0.03 
IIEF OF domain 10.0 (1.0, 10.0) 7.6 (6.3, 8.4) P=0.06 
IIEF SD domain 7.8 (7.3, 8.9) 6.9 (6.0, 8.6) P=0.05 
IIEF IS domain 12.0 (0.0, 15.0) 6.4 (5.5, 8.0) P=0.04 
IIEF OS domain 8.6 (7.5, 9.0) 6.4 (4.6, 7.4) p<0.01 
IPSS total score 3.2 (1.7, 3.8)  12.7 (12.4, 15.7) p<0.01 
IPSS IE  0.0 (0.0, 1.0) 3.5 (0.0, 5.0) P=0.01 
IPSS Freq  0.0 (0.0, 4.0) 3.0 (1.0, 5.0) P=0.002 
IPSS Intermit  0.0 (0.0, 2.0) 2.0 (0.0, 5.0) P=0.01 
IPSS Urgency  0.0 (0.0, 3.0) 2.0 (0.0, 5.0) P=0.01 
IPSS Weak stream  0.0 (0.0, 2.0) 2.0 (1.0, 5.0) p<0.01 
IPSS Strain  0.0 (0.0, 1.0) 1.0 (0.0, 2.0) P=0.02 
IPSS Nocturia  1.0 (0.0, 3.0) 2.0 (0.0, 5.0) P=0.02 
IPSS QoL  1.5 (0.0, 3.0) 3.5 (2.0, 6.0) p<0.01 
(EF: erectile function; OF: orgasmic function; SD: sexual desire; IS: intercourse satisfaction; OS: overall 
satisfaction; IE: incomplete emptying; Freq: frequency; Intermit: intermittency; Strain: straining; QoL: quality of 
life). 
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Figure Legends: 
Figure 1: The effect of bariatric surgery on BMI (A) of patients with ED (circles) and NO-ED 
(squares) at 1 month pre-op, 1 month post-op, 3 months post-op and 6 months post-op. 
*Significantly different from pre-op NO-ED (P<0.002); **significantly different from pre-op ED 
(P<0.001). The effect of bariatric surgery on %TWL (B) of patients with ED (circles) and NO-ED 
(squares) at day of surgery, 1 month post-op, 3 months post-op and 6 months post-op. 
*Significantly different from day of surgery NO-ED (P<0.002); **significantly different from 
day of surgery ED (P<0.001).  
Figure 2: The effect of bariatric surgery on BMI (A) of patients with NO-MILD LUTS (circles) 
and MODERATE-SEVERE LUTS (squares) at 1 month pre-op, 1 month post-op, 3 months post-
op and 6 months post-op. A significant decrease in BMI at 1 month post-op (A) and increase 
in %TWL (B) was observed after the surgery in NO-MILD LUTS and MODERATE-SEVERE LUTS.  
The weight loss reached statistical significance at 1 month post-op and continued throughout 
to 6 months post-op (*P<0.01 and **P<0.001) respectively. There was no difference between 
NO-MILD LUTS and MODERATE-SEVERE LUTS groups at any time points (P=0.925). 
Figure 3: The effect of bariatric surgery on total IIEF scores (A) of patients with ED (circles) 
and NO-ED (squares) at 1 month pre-op, 1 month post-op, 3 months post-op and 6 months 
post-op. *Significantly different from pre-op ED at 1, 3 and 6 months post-op (P=0.02, * 
=0.001 and P<0.001 respectively); **significantly different from pre-op NO-ED at 6 months 
post-op (P=0.013). Erectile function domain (B) and orgasmic function, sexual desire, 
intercourse satisfaction and overall satisfaction domains (C) of patients with ED at pre-op, 1 
month post-op, 3 months post-op and 6 months post-op. *Erectile function and intercourse 
satisfaction domains significantly different from pre-op (P<0.02 and P<0.004 respectively); 
**sexual desire domain significantly different from pre-op (P<0.002); ***orgasmic function 
domain significantly different from pre-op (P<0.004).  
Figure 4: The effect of bariatric surgery on IPSS total score in ED (circles) and NO-ED 
(squares) groups at 1 month pre-op, 1 month post-op, 3 months post-op and 6 months post-
op. A: The improvements in IPSS total score in ED group was observed at 1 month which 
further improved throughout the study; *significantly different from pre-op ED at 1, 3 and 6 
months post-op (P=0.02, P=0.001 and P<0.001 respectively). No significant change was 
observed in NO-ED group throughout the study (P=0.928, P=0.179 and P=0.107 respectively). 
B: The effect of bariatric surgery on IPSS domains scores in ED group only. Please see 
Supplementary Figure 3 for NO-ED group. The improvements in frequency, intermittency, 
weak stream, nocturia and quality of life domain scores were observed at 1 month post-op 
(*P=0.01, *P=0.008, *P=0.005, *P=0.024 and *P=0.001 respectively) and further improved 
throughout the study. The decrease in urgency and incomplete emptying domain scores 
reached significance at 3 months post-op (**P=0.023 and **P=0.007 respectively). There was 
no significant change in straining domain score throughout the study (P=0.81)  
Figure 5: The effect of bariatric surgery on IPSS total score in MODERATE-SEVERE LUTS 
(squares) and NO-MILD LUTS (circles)  groups (A): The improvements in IPSS total score in 
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MODERATE-SEVERE LUTS was observed at 1 month which further improved throughout the 
study (*P=0.02, *P=0.001 and *P=0.001 respectively). No significant improvement observed 
in NO-MILD LUTS group throughout the study (P=0.833, P=0.241 and P=0.138 respectively). 
The effect of bariatric surgery on IPSS domains scores in MODERATE-SEVERE LUTS group only. 
For NO-MILD LUTS results please see Supplementary Figure 4. Significant improvements in 
frequency, intermittency, weak stream and nocturia domains were observed at 1, 3 and 6 
months post-operative time points (P=0.04, P=0.017 and P=0.002) (P=0.02, P=0.016 and 
P=0.01) (P=0.008, P=0.007 and P=0.002) (P=0.004, P=0.006 and P=0.002) respectively. A 
significant improvement in IPSS- straining at 3 months post-op was observed but did not 
continue to 6 months post-op (**P=0.033, P=0.154 respectively).  
Figure 6: The effect of bariatric surgery on fasting blood glucose concentrations (FBG, A) and 
glycated haemoglobin concentrations (HbA1c, B) in ED (circles) and NO-ED (squares) groups. 
The decrease in FBG levels reached significance at 1 months post-op in ED group (*P<0.001) 
and at 6 months post-op in NO-ED group (**P=0.047). The decrease in HbA1c levels reached 
significance at 1 month pre-op in both ED (*P<0.001) and NO-ED groups (**P<0.004). The 
upper limits of the normal range (FBG 5.8 mmol/l and HbA1c 42 mmol/mmol) are shown with 
broken lines.  
Figure 7: The effect of bariatric surgery on fasting blood glucose concentrations (FBG, A) and 
glycated haemoglobin concentrations (HbA1c, B) in NO-MILD LUTS (circles) and MODERATE-
SEVERE LUTS (squares) groups. The decrease in FBG levels reached significance at 1 months 
post-op in both groups (A; *P<0.005, **P<0.003). The decrease in HbA1c levels reached 
significance at 1 month pre-op in both NO-MILD LUTS group (*P<0.001) and MODERATE-
SEVERE LUTS groups (**P<0.003). The upper limits of the normal range (FBG 5.8 mmol/l and 
HbA1c 42 mmol/mmol) are shown with broken lines.  
 
Supplementary Figure Legends: 
Supplementary Figure 1:  
The effect of bariatric surgery on IIEF domains scores in NO-ED group: Erectile function 
domain (A) and orgasmic function, sexual desire, intercourse satisfaction and overall 
satisfaction domains (B) of patients with NO-ED at 1 month pre-op, 1 month post-op, 3 
months post-op and 6 months post-op. *Sexual desire and intercourse satisfaction domains 
significantly different from pre-op (P<0.02 and P<0.01 respectively). 
Supplementary Figure 2:  
The effect of bariatric surgery on IIEF total scores (A) and erectile function domain (B) and the 
remaining individual domain scores (C) in MODERATE-SEVERE LUTS (squares) and NO-MILD 
LUTS (circles) groups: A: The total IIEF scores increased significantly after the surgery at 3 
months and 6 months post-op in both groups (*P<0.002 in NO-MILD LUTS and **P<0.003 in 
MODERATE-SEVERE LUTS). B: Erectile function domain scores remained high in NO-MILD LUTS 
group throughout the study while increased significantly in MODERATE-SEVERE LUTS group 
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from 1 month post-op onwards (**P<0.05 vs pre-op). C: Intercourse satisfaction and orgasmic 
function domains showed significant increase at 1 month post-op MODERATE-SEVERE LUTS 
group while the remaining domains improved at 6 months post-op (*P<0.05). In NO-MILD 
LUTS group, only significant increase was observed in desire, intercourse satisfaction, 
orgasmic function and overall satisfaction domains at 6 months (**P<0.05).   
Supplementary Figure 3:  
In the NO-ED group there was a significant increase in quality of life domain score at 1 month 
post-op compared to 1 month pre-op; this effect was not observed at 3 months post-op or 6 
months post-op (*P=0.046 at 1 month post-op vs pre-op). A significant decrease in nocturia 
at 6 months post-op compared to 1 month pre-op (**P=0.027) was observed.  
Supplementary Figure 4:  
In the NO-MILD LUTS group a significant improvement in nocturia and urgency domains was 
observed at 3 and 6 months post-operative time points (*P=0.035, *P=0.046) and (**P=0.031, 
**P=0.041) respectively.   
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